(Q45960402)

18 December 2017

title

Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. (English)

1 reference

18 December 2017

1 reference

1 reference

D Mauricio

15

0 references

author name string

C A Fernández

1

1 reference

18 December 2017

M Puig-Domingo

2

1 reference

18 December 2017

F Lomeña

3

1 reference

18 December 2017

M Estorch

4

1 reference

18 December 2017

V Camacho Martí

5

1 reference

18 December 2017

A L Bittini

6

1 reference

18 December 2017

M Marazuela

7

1 reference

18 December 2017

J Santamaría

8

1 reference

18 December 2017

J Castro

9

1 reference

18 December 2017

P Martínez de Icaya

10

1 reference

18 December 2017

I Moraga

11

1 reference

18 December 2017

T Martín

12

1 reference

18 December 2017

A Megía

13

1 reference

18 December 2017

M Porta

14

1 reference

18 December 2017

I Halperin

16

1 reference

18 December 2017

publication date

1 March 2009

1 reference

18 December 2017

Journal of Endocrinological Investigation

published in

1 reference

18 December 2017

volume

32

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

228-233

1 reference

18 December 2017

Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

RAR and RXR modulation in cancer and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Retinoic acid redifferentiation therapy for thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Management of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346457

Redifferentiation therapy-induced radioiodine uptake in thyroid cancer

21 January 2018

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.

1 reference

12 December 2020

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

1 reference

12 December 2020

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer

1 reference

12 December 2020

Iodide symporter gene expression in human thyroid tumors

1 reference

12 December 2020

Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma

1 reference

12 December 2020

Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma

1 reference

12 December 2020

Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma

1 reference

12 December 2020

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346457

1 reference

18 December 2017

Dimensions Publication ID

1044589186

0 references

1 reference

18 December 2017